SCHEMBL7379657

SCHEMBL7379657

CC(=O)c1c(C)cc(=O)[nH]c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
PTBP1 P26599 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.40
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
BRD4 O60885 2/20 0.39
UPP1 Q16831 1/20 0.39
JAK1 P23458 1/20 0.39
BRPF1 P55201 1/20 0.39
CREBBP Q92793 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3958910 0.83 NOTUM (0.50) CYP1A2CYP3A4SMN1; SMN2HPGDLMNA
SCHEMBL4698108 0.82 MAPT (0.54) CYP1A2HPGDLMNAHSD17B10MAPT
SCHEMBL4105190 0.76 ALDH1A1 (0.61) CYP1A2CYP3A4SMN1; SMN2HPGDLMNA
SCHEMBL4519599 0.75 ALDH1A1 (0.61) SMN1; SMN2LMNAMAPTKDM4EGAA
SCHEMBL29025896 0.71 CYP1A2 (0.61) CYP1A2CYP3A4SMN1; SMN2HPGDHSD17B10
SCHEMBL7373895 0.71 MAPT (0.36) CYP1A2CYP3A4SMN1; SMN2HPGDLMNA
SCHEMBL7373896 0.71 MAPT (0.36) CYP1A2CYP3A4SMN1; SMN2HPGDLMNA
SCHEMBL3188766 0.71 CYP1A2 (0.45) CYP1A2CYP3A4SMN1; SMN2HPGDHSD17B10
SCHEMBL4928504 0.70 KDM4E (0.47) CYP1A2SMN1; SMN2HPGDLMNAHSD17B10
SCHEMBL4518905 0.69 CYP3A4 (0.44) CYP1A2CYP3A4SMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0134535-B1 1,6-NAPHTHYRIDIN DERIVATIVES USEFUL AS CARDIOTONICS AND PREPARATION THEREOF STERLING DRUG INC. (US) 1988-10-26 EP disclosed
EP-0101952-B1 5-ALKYL-1,6-NAPHTHYRIDIN-2(1H)-ONES, INTERMEDIATES, THEIR PREPARATION AND THEIR CARDIOTONIC USE STERLING DRUG INC. (US) 1987-09-23 EP disclosed
EP-0204335-A2 2(1H)-Pyridin-ones useful as intermediates STERLING DRUG INC. (US) 1986-12-10 EP disclosed
US-4604399-A 5-methyl(or ethyl)-1,6-naphthyridin-2(1H)-one 6-oxides, their preparation and the cardiotonic use thereof STERLING DRUG INC. (US) 1986-08-05 US disclosed
US-4559347-A 3-Substituted-5-alkyl-1,6-naphthyridin-2(1H)-ones, cardiotonic use and preparation thereof STERLING DRUG INC. (US) 1985-12-17 US disclosed
US-4532247-A Increases cardiac contractility STERLING DRUG INC. (US) 1985-07-30 US disclosed
US-4524149-A 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use STERLING DRUG INC. (US) 1985-06-18 US disclosed
US-4517190-A 5-Alkyl-1,6-naphthyridin-2(1H)-ones and cardiotonic use thereof STERLING DRUG INC. (US) 1985-05-14 US disclosed
EP-0134535-A1 1,6-Naphthyridin derivatives useful as cardiotonics and preparation thereof STERLING DRUG INC. (US) 1985-03-20 EP disclosed
EP-0101952-A1 5-Alkyl-1,6-naphthyridin-2(1H)-ones, intermediates, their preparation and their cardiotonic use STERLING DRUG INC. (US) 1984-03-07 EP disclosed
US-4415580-A Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same STERLING DRUG INC. (US) 1983-11-15 US disclosed
US-4412077-A Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone STERLING DRUG INC. (US) 1983-10-25 US disclosed
EP-0089022-A2 Alkanoylpyridinones useful as cardiotonics and preparation thereof STERLING DRUG INC. (US) 1983-09-21 EP disclosed